Detalhe da pesquisa
1.
Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) Study.
Crit Care Med
; 51(6): 808-816, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917594
2.
Identification of a sub-group of critically ill patients with high risk of intensive care unit-acquired infections and poor clinical course using a transcriptomic score.
Crit Care
; 27(1): 158, 2023 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085849
3.
State of the Art Procedures for the Isolation and Characterization of Mesoangioblasts.
Methods Mol Biol
; 2640: 99-115, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995590
4.
PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB.
J Biol Chem
; 286(7): 5691-707, 2011 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21127072
5.
A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19.
Front Immunol
; 13: 939899, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045686
6.
Mortality Prediction in Sepsis With an Immune-Related Transcriptomics Signature: A Multi-Cohort Analysis.
Front Med (Lausanne)
; 9: 930043, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847809
7.
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.
Ann Intensive Care
; 12(1): 21, 2022 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35246776
8.
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19.
EBioMedicine
; 78: 103967, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349827
9.
A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients.
Front Immunol
; 13: 1022750, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36389738
10.
Seroconversion in septic ICU patients presenting with COVID-19: necessary but not sufficient.
Arch Med Res
; 52(8): 850-857, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538689
11.
Monocyte Trajectories Endotypes Are Associated With Worsening in Septic Patients.
Front Immunol
; 12: 795052, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34912347
12.
Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries-Insights from the REALISM Study.
J Clin Med
; 11(1)2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35011836
13.
MICAL2 is essential for myogenic lineage commitment.
Cell Death Dis
; 11(8): 654, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811811
14.
Classification of prostatic diseases by means of multivariate analysis on in vivo proton MRSI and DCE-MRI data.
NMR Biomed
; 22(10): 1036-46, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19579258
15.
PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C.
Mol Cell Biol
; 25(6): 2242-59, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15743821
16.
Monocyte HLA-DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds.
Cytometry B Clin Cytom
; 104(6): 468-470, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226415
17.
NMR-based metabolic profiling of human hepatoma cells in relation to cell growth by culture media analysis.
Biochim Biophys Acta
; 1760(11): 1723-31, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17052856
18.
Dissecting drug and vehicle metabolic effects in rats by a metabonomic approach.
J Biochem Biophys Methods
; 70(3): 355-61, 2007 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-17011038
19.
Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.
Ann Intensive Care
; 12(1): 30, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362873
20.
Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.
Oncotarget
; 7(46): 74747-74767, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27732969